VISN [VISIONCHINA MEDIA] SC 13G: JOINT FILING AGREEMENT Prescott Group Capital Management, L.L.C.

[JOINT FILING AGREEMENT Prescott Group Capital Management, L.L.C. PHIL FROHLICH, Managing Member Prescott Group Aggressive Small Cap, L.P. PHIL FROHLICH, Managing Member Prescott Group Aggressive Small Cap II, L.P. PHIL FROHLICH, Managing Member Phil Frohlich 2 EX-99.1 2 d486603dex991.htm EX-1] [CUSIP No. 92833U103 13G 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Prescott Group Capital Management, L.L.C. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ (a) ¨ (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Oklahoma]

By | 2016-03-29T22:34:55+00:00 February 14th, 2013|Categories: Chinese Stocks, VISN, Webplus ver|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] SC 13G/A: SCHEDULE 13G CUSIP No. 206277 105 Page 2

[SCHEDULE 13G CUSIP No. 206277 105 Page 2 of 8 Pages 1 Name of reporting person China Medical Scientific Holdings Limited (Formerly known as Notable Enterprise Limited) 2 Check the appropriate box if a member of a group ¨]

TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended December 31, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended December 31, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director]

By | 2016-03-27T18:46:56+00:00 February 14th, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments

YOKU [YOUKU TUDOU] SC 13G/A: 1. NAME OF REPORTING PERSON S.S. OR I.R.S.

[1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Janus Capital Management LLC EIN #75-3019302 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP a. ___ b. _X_ 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5. SOLE VOTING POWER 8,291,563**]

MR [Mindray Medical International] SC 13G: USIP O C 13G Page 2 of 15

[USIP O C 13G Page 2 of 15 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OFOVE PERSONmmonwealth Bank of Australia 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A x (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Australianpital Territory,mmonwealth of Australia] [USIP O C 13G Page 14 of 15 Joint Filingreement February 14, 2013 Thisreement may be executed in multipleunterparts, each of which shallnstitute an original, one and theme instrument.mmonwealth Bank of Australia Johnmien Hattonmpany Secretarylonialmpany Limited Johnmien Hatton Director] [USIP O C 13G Page 15 of 15 Item7 Information The securities being reported on by the reporting persons herein parentmpanies are owned, or may be deemed to be beneficially owned follows:mpany Type ofmpany. First State Investments (Hong Kong) Limited IA (HK registered) First State Investments International]

DQ [DAQO NEW ENERGYRP.] SC 13G/A: 1 Name of reporting person STYLE=”font-family:Times New Roman”

[1 Name of reporting person STYLE="font-family:Times New Roman" SIZE="3">Fei Ge (Mr. Ge) 2 Check the appropriate box if a member of a (a) 3 SEC use only 4 Citizenship or place of organization Peoples Republic of China Numberof shares beneficially ownedby each reporting person with: 5 Sole voting power 11,471,250 ordinary shares, whichnsist of (i)]

By | 2016-02-06T15:59:42+00:00 February 14th, 2013|Categories: Chinese Stocks, DQ, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] SC 13G: 1. Names of Reporting Persons. Popeset Management, I.R.S.

[1. Names of Reporting Persons. Popeset Management, I.R.S. Identification Nos. ofove persons 62-1871308 2. Check the Appropriate Box if a Member of a (a) (b) 3. SEC Use Only 4. Citizenship or Place of Organization Tennessee Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power 2,224,831* 6. Shared Voting Power]

By | 2016-02-07T21:44:41+00:00 February 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

XUE [Xueda Education] SC 13G/A: Joint Filing Agreement Remainder of this page has

[Joint Filing Agreement Remainder of this page has been left intentionally blank [ Xin Jin Xin Jin Golden Section Holding Corporation] [(1) This CUSIP number applies to the Issuer’s American Depositary Shares, each representing two Ordinary Shares. CUSIP No. 98418W109 Schedule 13G]

By | 2016-03-18T09:51:00+00:00 February 14th, 2013|Categories: Chinese Stocks, Webplus ver, XUE|Tags: , , , , , |0 Comments

MR [Mindray Medical International] SC 13G/A: Common Stock 602675100 December 31, 2012 [X]Rule 13d-1(b)

[Common Stock 602675100 December 31, 2012 [X]Rule 13d-1(b) * The remainder of thisver page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a priorver page.]

Skip to toolbar